3-Methyl-8-cinnamoyl-3,8-diazabicyclo[3.2.1]octane-2,4-dione(35139-98-1)
- Name: 3-Methyl-8-cinnamoyl-3,8-diazabicyclo[3.2.1]octane-2,4-dione
- Synonyms:3-Methyl-8-cinnamoyl-3,8-diazabicyclo[3.2.1]octane-2,4-dione;3-Methyl-8-[(E)-(3-phenyl-acryloyl)]-3,8-diaza-bicyclo[3.2.1]octane-2,4-dione;3-Methyl-8-phenyl-3,8-diazabicyclo<3.2.1>octan-2,4-dion;
- Molecular Formula:C16H16N2O3
- Molecular Weight:284.3098
- CAS Registry Number:35139-98-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.35139-98-1 3-Methyl-8-cinnamoyl-3,8-diazabicyclo[3.2.1]octane-2,4-dione
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.35139-98-1 3-Methyl-8-cinnamoyl-3,8-diazabicyclo[3.2.1]octane-2,4-dione
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.35139-98-1 3-Methyl-8-cinnamoyl-3,8-diazabicyclo[3.2.1]octane-2,4-dione
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:3-Methyl-8-cinnamoyl-3,8-diazabicyclo[3.2.1]octane-2,4-dione
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 61536-00-3/IN 3501
- 339155-58-7/Efalizumab
- 23220-52-2/MESO-2 3-DIAMINOSUCCINIC ACID
- 76267-14-6/N-ethyl-N-(2-methylphenyl)dicarbonimidic diamide
- 118638-18-9/1-{[(1-methylethyl)amino]methyl}-6,7,8,9-tetrahydrodibenzo[b,d]furan-2-ol hydrochloride
- 62055-15-6/GC-44
- 83753-42-8/L-Phenylalanine,L-R-glutamyl-L-histidyl-Lphenylalanyl- D-lysyl-
- 90269-08-2/Cerium, 2-ethylhexanoate naphthenate complexes
- 3973-18-0/Propynol ethoxylate
- 114566-61-9/4-methyl-6-[2-(phenylamino)-1,3-thiazol-4-yl]-2H-1,4-benzoxazin-3(4H)-one
- 63931-65-7/4-phenyl-1,4-dihydro-5H-1,2,4-benzotriazepin-5-one
- 16024-82-1/METHYL 2-ISOTHIOCYANATOBENZOATE
- 59049-80-8/tert-butyl(ethyl)mercury
- 94247-10-6/isodecyl laurate
- 93940-78-4/l-Proline, 5-oxo-, compd. with (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
- 33639-59-7/2,3-dimethyl-5-[(2-methyl-1H-indol-3-yl)azo]-1-phenyl-1H-pyrazolium chloride
- 13761-06-3/(1aR,2R,6R,6aS,7aS,9aS)-2-(Acetyloxy)-1a,6,6a,8,9,9a-hexahydro-1a,5-dimethyl-2H-6,7a-(epoxymethano)bisoxireno[4,5:8,9]cyclodeca[1,2-b]furan-10-one
- 3453-99-4/2,2-Dimethoxybutane
- 35139-98-1/3-Methyl-8-cinnamoyl-3,8-diazabicyclo[3.2.1]octane-2,4-dione
- 6186-92-1/N~2~-(3-chloro-4-methoxyphenyl)-N-(3,4-dimethylphenyl)-N~2~-(methylsulfonyl)glycinamide
- 77562-92-6/1-Piperazineethanamine, alpha-methyl-N-phenyl-4-(2-phenylethyl)-, etha nedioate, hydrate (2:4:1)
- 68990-90-9/Tall oil, diethylenetriamine imidazoline
- 117056-11-8/hemoglobin Sunnybrook
- 70481-66-2/3,6,10-trimethylbenzo[g]pteridine-2,4(3H,10H)-dione
- 23462-89-7/(11alpha,14beta,17alpha)-gona-1(10),2,4,6,8-pentaene-11,17-diol
- 19368-32-2/2-[(5-chloro-2-methylphenyl)carbamoyl]benzoic acid
- 2513-25-9/2,2-Dimethyl-2H-1-benzopyran
- 77099-06-0/(+)-(10,11-dihydro-5-methyl-5H-dibenzo[a,d]cyclohepten-5,10-diyl)ammonium hydrogen [S-(R*,R*)]-2,3-bis(p-toluoyloxy)succinate
- 20186-11-2/P 497
- 51837-72-0/2-(2,5-dimethoxy-4-methylbenzoyl)-3-methoxybenzoic acid